Shantani’s portfolio of services, based on advanced chemical proteomics technologies, helps in identifying and validating drug targets of small molecules. It allows early de-risking of drug-discovery programs and supports crucial Go/No-Go decisions throughout the drug discovery process. Based on the discovery program’s need, we offer several Target ID technologies:
We provide rapid and path forwarding solutions to complex bioanalytical and biopharma product development problems. Shantani’s professional team of experts has more than a decade of experience in high-resolution mass spectrometry, optical spectroscopy, cell biology, biopharmaceutical production and QC/Regulatory processes. Our consultative approach, availability of high-end instrumentation and utilization of cutting-edge technologies help us provide high-quality data at rapid turnaround time.